A safety-aware intake modeling framework for translating edible algal biomass into nutritional bioproducts
Advanced Biotechnology · 10.08.2026 · 4 (3)
DOI: 10.1007/s44307-026-00129-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biotechnology, online erschienen am 10.08.2026. Verfasst von Yu Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences and Bioengineering, University of Hawai'i at Mānoa, Honolulu, Hawai'i, 96822, USA. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Hawai'i at Mānoa, National Institute of Food and Agriculture, Institute of Clinical and Translational Sciences.
Abstract (Originalsprache)
Edible algal biomass has emerged as a promising platform for nutritional bioproduct development, but its practical translation depends on compositional variability, intake feasibility, and safety constraints. Here, we integrated biochemical profiling, trace element screening, age-specific intake modeling, and community consumption context to evaluate commercially available and supplier-provided microalgal and seaweed products within realistic application boundaries. Selected products differed substantially in macronutrient composition, fatty acid profiles, pigments, polyphenols, and mineral composition, indicating product- and species-specific roles as nutritional biomass rather than interchangeable ingredients. Across species and age groups, approximately 0.7 to 3.1 g dry biomass provided 20% of age-specific alpha-linolenic acid intake, with approximately 1 g sufficient for several products. Multi-species allocations improved omega-3 representation while remaining within practical intake limits and trace element-based screening thresholds. Community consumption data from Pacific Island children showed low and episodic seaweed intake, highlighting a gap between biomass potential and routine dietary use. These findings support safety-aware modeling as a preliminary screening and decision-support strategy for evaluating edible algal biomass before further product-specific validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biosciences and Bioengineering, University of Hawai'i at Mānoa, Honolulu, Hawai'i, 96822, USA.
- Department of Human Nutrition, Food and Animal Sciences, University of Hawai'i at Mānoa, Honolulu, Hawai'i, 96822, USA.
- Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, 61300, Brno, Czech Republic.
- Research Center for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 65653, Brno, Czech Republic.
- Water Resources Research Center, University of Hawai'i at Mānoa, Honolulu, Hawai'i, 96822, USA.
- University of Hawai'i Cancer Center, Honolulu, Hawai'i, 96822, USA.
Förderung
- University of Hawai'i at Mānoa
- National Institute of Food and Agriculture
- Institute of Clinical and Translational Sciences
Zitieren
APA
Wang, Y., Roell, G., Cruz, R. D., Durďáková, M., Maruwan, J., Rong, K., Novotny, R., Esquivel, M., Wilkens, L., Su, W. W., Yan, T., Ho, K., & Du, Z. Y. (2026). A safety-aware intake modeling framework for translating edible algal biomass into nutritional bioproducts. Advanced Biotechnology, 4(3). https://doi.org/10.1007/s44307-026-00129-4
Vancouver
Wang Y, Roell G, Cruz RD, Durďáková M, Maruwan J, Rong K, et al. A safety-aware intake modeling framework for translating edible algal biomass into nutritional bioproducts. Advanced Biotechnology. 2026;4(3). doi:10.1007/s44307-026-00129-4
BibTeX
@article{Wang2026,
author = {Wang, Yu and Roell, Garrett and Cruz, Rica Dela and Durďáková, Michaela and Maruwan, Jessica and Rong, Kexin and Novotny, Rachel and Esquivel, Monica and Wilkens, Lynne and Su, Wei Wen and Yan, Tao and Ho, Kacie and Du, Zhi-Yan},
title = {A safety-aware intake modeling framework for translating edible algal biomass into nutritional bioproducts},
journal = {Advanced Biotechnology},
year = {2026},
volume = {4},
number = {3},
doi = {10.1007/s44307-026-00129-4}
}
EUVIMED